GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » Cyclically Adjusted Revenue per Share

Cosmo Bio Co (TSE:3386) Cyclically Adjusted Revenue per Share : 円1,451.98 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Cosmo Bio Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cosmo Bio Co's adjusted revenue per share for the three months ended in Dec. 2023 was 円422.108. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円1,451.98 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Cosmo Bio Co's average Cyclically Adjusted Revenue Growth Rate was 4.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cosmo Bio Co was 4.80% per year. The lowest was 2.50% per year. And the median was 3.40% per year.

As of today (2024-04-28), Cosmo Bio Co's current stock price is 円986.00. Cosmo Bio Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円1,451.98. Cosmo Bio Co's Cyclically Adjusted PS Ratio of today is 0.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cosmo Bio Co was 1.06. The lowest was 0.57. And the median was 0.83.


Cosmo Bio Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cosmo Bio Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Bio Co Cyclically Adjusted Revenue per Share Chart

Cosmo Bio Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,255.42 1,260.58 1,302.88 1,387.68 1,451.98

Cosmo Bio Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,387.68 1,401.18 1,418.76 1,436.84 1,451.98

Competitive Comparison of Cosmo Bio Co's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Cosmo Bio Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Bio Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's Cyclically Adjusted PS Ratio falls into.



Cosmo Bio Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cosmo Bio Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=422.108/106.8000*106.8000
=422.108

Current CPI (Dec. 2023) = 106.8000.

Cosmo Bio Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 369.939 95.700 412.847
201406 249.831 98.000 272.265
201409 265.013 98.500 287.344
201412 335.695 97.900 366.213
201503 392.881 97.900 428.597
201506 253.711 98.400 275.369
201509 270.074 98.500 292.832
201512 324.393 98.100 353.162
201603 391.869 97.900 427.493
201606 280.027 98.100 304.861
201609 278.846 98.000 303.885
201612 302.126 98.400 327.917
201703 371.964 98.100 404.952
201706 252.024 98.500 273.261
201709 259.278 98.800 280.272
201712 309.042 99.400 332.049
201803 387.314 99.200 416.987
201806 253.374 99.200 272.786
201809 262.989 99.900 281.153
201812 321.188 99.700 344.061
201903 362.348 99.700 388.152
201906 277.665 99.800 297.141
201909 303.812 100.100 324.147
201912 336.538 100.500 357.634
202003 408.232 100.300 434.688
202006 257.422 99.900 275.202
202009 317.139 99.900 339.043
202012 382.254 99.300 411.125
202103 490.708 99.900 524.601
202106 338.172 99.500 362.983
202109 353.246 100.100 376.890
202112 405.732 100.100 432.889
202203 526.070 101.100 555.730
202206 355.372 101.800 372.826
202209 346.690 103.100 359.132
202212 417.340 104.100 428.164
202303 486.496 104.400 497.680
202306 342.940 105.200 348.156
202309 351.268 106.200 353.253
202312 422.108 106.800 422.108

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cosmo Bio Co  (TSE:3386) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cosmo Bio Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=986.00/1451.98
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cosmo Bio Co was 1.06. The lowest was 0.57. And the median was 0.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cosmo Bio Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cosmo Bio Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Bio Co (TSE:3386) Business Description

Traded in Other Exchanges
N/A
Address
2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co (TSE:3386) Headlines

No Headlines